Table 2.
Comparison of demographic characteristics of patients by initial linkage manager assignment and baseline linkage meeting completion.
| Assigned | Baseline linkage meeting completed | ||||
|---|---|---|---|---|---|
| F-LM (n = 7) | R-LM (n = 9) | F-LM (n = 7)a | R-LM (n = 9) | ||
| All | 7 (100%) | 9 (100%) | 6 (86%) | 5 (56%) | |
| Age | |||||
| 35–44 | 2 (29%) | 3 (33%) | 2 (100%) | 2 (67%) | |
| 45–54 | 1 (14%) | 3 (33%) | 1 (100%) | 1 (33%) | |
| 55+ | 4 (57%) | 3 (33%) | 3 (75%) | 2 (67%) | |
| Gender | |||||
| Female | 4 (57%) | 2 (22%) | 4 (100%) | 0 (0%) | |
| Male | 3 (43%) | 7 (78%) | 2 (67%) | 5 (71%) | |
| Race | |||||
| Black | 5 (71%) | 7 (78%) | 4 (80%) | 5 (71%) | |
| White | 2 (28%) | 2 (22%) | 2 (100%) | 0 (0%) | |
| Any use in past 30 days | F-LM (n = 6)a,b | R-LM (n = 5)b | |||
| Any substances | – | – | 6 (100%) | 3 (60%) | |
| Alcohol | – | – | 2 (33%) | 3 (60%) | |
| Marijuana | – | – | 0 (0%) | 1 (20%) | |
| Cocaine | – | – | 3 (50%) | 2 (40%) | |
| Other stimulants | – | – | 1 (17%) | 0 (0%) | |
| Opioids | – | – | 6 (100%) | 2 (40%) | |
All patients were non-Hispanic/Latino; aan extra patient was enrolled because of the interview recording failed; bsubstance use only assessed if patient completed baseline linkage meeting.